유나이티드제약

033270KOSPI의약품 제조업

60.5 / 100

Reference Date: 2026-06-10

Financial Score29.5 / 40

News Sentiment19.0 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: ROE significantly exceeds the industry average but Operating Profit is on a declining trend. Declined 8.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

United Pharmaceutical is a specialized generic drug manufacturer focusing on improved drugs, achieving sales of 2.887 trillion won in 2024 with a 20% operating profit margin through key products like Silostan CR Tablets and Artmax Combi Gel. The company maintains advanced production facilities and R&D capabilities, exporting pharmaceuticals to over 40 countries and launching 17 improved drug formulations.

Number of Employees

902people

Average Salary

67.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.93Industry Average 11.936.5Point

Lower than industry avg (good)

PBR

0.63Industry Average 0.895.5Point

Lower than industry avg (good)

ROE

8.90Industry Average 4.017.0Point

2.2x industry avg (excellent)

Debt Ratio

3.76Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼4.7% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 10.2% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 76

Positive
식약처, 악성 흑색종 치료 '디티아이주' 국가필수약 지정·주문제조
유나이티드제약의 주요 성분 다카르바진이 국가필수약으로 지정되어 악성암 치료에 대한 안정적 공급이 보장되어 회사의 긍정적 전망을 반영합니다.
Positive
한국유나이티드제약, 개량신약 '라베듀오정' UAE 첫 수출
유나이티드제약의 개량신약 라베듀오정 UAE 수출 성공으로 인해 중동 시장 진출 확대 기대감 상승.
Positive
[바이오스냅] HK이노엔, 반려동물 아토피약 품목허가 신청
유나이티드제약의 반려동물 아토피 치료제 수출 소식으로 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 18,110Won52-week high 22,35052-week low 18,000

1-month return1.0Point

1m -8.77% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 4Negative 1

Neutral주식등의대량보유상황보고서(일반)2026-06-02
Neutral최대주주등소유주식변동신고서2026-06-02
Neutral기업지배구조보고서공시2026-05-29
Negative소송등의판결ㆍ결정(일정금액이상의청구)2026-05-29
Neutral분기보고서 (2026.03)2026-05-14